A Randomized, Double-blind Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-hydrin) and Halobetasol Propionate Ointment 0.05% (Ultravate) in the Treatment and Maintenance of Psoriasis.

Trial Profile

A Randomized, Double-blind Study to Evaluate the Efficacy of Ammonium Lactate Lotion 12% (Lac-hydrin) and Halobetasol Propionate Ointment 0.05% (Ultravate) in the Treatment and Maintenance of Psoriasis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2016

At a glance

  • Drugs Ammonium lactate (Primary) ; Ulobetasol (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Feb 2011 Results presented at the 69th Annual Meeting of the American Academy of Dermatology.
    • 03 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top